FAAS
MRNA icon

First Allied Advisory Services’s Moderna MRNA Stock Holding History

First Allied Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$637K Sell
9,007
-1,886
-17% -$131K 0.02% 611
2020
Q2 		$699K Buy
+10,893
New +$597K 0.03% 551

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Allied Advisory Services's MRNA Position: Q3 2020 in Review

First Allied Advisory Services reduced its Moderna (MRNA) stake by 17% in Q3 2020, selling an estimated $131K and leaving 9,007 shares worth $637K. The position accounts for 0.02% of the portfolio, ranked #611.

First Allied Advisory Services first reported a position in MRNA in Q2 2020 and has held it in 2 quarters since. The position peaked at $699K in Q2 2020. 547 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

  • First Allied Advisory Services held 9,007 shares of Moderna worth $637K as of Q3 2020.
  • First Allied Advisory Services sold 1,886 Moderna shares in Q3 2020, an estimated $131K.
  • Moderna made up 0.02% of First Allied Advisory Services's portfolio in Q3 2020, its #611 holding.
  • First Allied Advisory Services first reported a position in Moderna in Q2 2020 and has held it in 2 quarters since.
  • First Allied Advisory Services's Moderna position peaked at $699K in Q2 2020.
  • 547 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.